{"id":"NCT04707768","sponsor":"Akebia Therapeutics","briefTitle":"Study Evaluating the Efficacy and Safety of Dose Conversion From a Long-acting Erythropoiesis-stimulating Agent (Mircera®) to Three Times Weekly Oral Vadadustat for the Maintenance Treatment of Anemia in Hemodialysis Subjects","officialTitle":"A Randomized, Open-label, Active-controlled Study Evaluating the Efficacy and Safety of Dose Conversion From a Long-acting Erythropoiesis-stimulating Agent (Mircera®) to Three Times Weekly Oral Vadadustat for the Maintenance Treatment of Anemia in Hemodialysis Subjects","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2021-06-18","primaryCompletion":"2023-01-06","completion":"2023-01-30","firstPosted":"2021-01-13","resultsPosted":"2025-01-15","lastUpdate":"2025-01-15"},"enrollment":456,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Anemia Associated With Chronic Kidney Disease (CKD)"],"interventions":[{"type":"DRUG","name":"Vadadustat","otherNames":[]},{"type":"DRUG","name":"Mircera®","otherNames":[]}],"arms":[{"label":"Vadadustat low dose","type":"EXPERIMENTAL"},{"label":"Vadadustat high dose","type":"EXPERIMENTAL"},{"label":"Mircera®","type":"ACTIVE_COMPARATOR"}],"summary":"This study will be conducted to demonstrate the efficacy and safety of vadadustat administered three times weekly (TIW) compared to a long-acting erythropoiesis-stimulating agent (ESA) (Mircera®) for the maintenance treatment of anemia in hemodialysis participants.","primaryOutcome":{"measure":"Change From Baseline in Hemoglobin (Hb) to the Average Over the Primary Evaluation Period (PEP) (Weeks 20 to 26)","timeFrame":"Baseline; Weeks 20 to 26","effectByArm":[{"arm":"Vadadustat 600 mg TIW","deltaMin":-0.07,"sd":0.095},{"arm":"Vadadustat 900 mg TIW","deltaMin":0.14,"sd":0.095},{"arm":"Mircera®","deltaMin":0.36,"sd":0.092}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":8},"locations":{"siteCount":58,"countries":["United States"]},"refs":{"pmids":["39521398","39231617"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":68,"n":151},"commonTop":["COVID 19","Diarrhoea","Nausea","Hyperkalaemia","Fall"]}}